Adipose Tissue Expandability and Type 2 Diabetes

NCT03155412 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2020-02-13

No results posted yet for this study

Summary

The goal of the study is to analyze deviations in adipogenic potential and metabolic properties of preadipocytes in subjects with genetic predisposition to type 2 diabetes, and thus identify factors that underlie hypertrophic growth of adipose tissue associated with the development of this disease.

Conditions

  • Type2 Diabetes Mellitus

Sponsors & Collaborators

  • Charles University, Czech Republic

    lead OTHER

Principal Investigators

  • Vladimir Stich, prof · Third faculty of medicine, Charles University in Prague

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-03-31
Completion
2019-01-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03155412 on ClinicalTrials.gov